Evidence map›Paper›PMID 38431747›Full record

ArticleLeukemia2024

Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol.

Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas Gupta, Dawn Maze, Karen W L Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard-Carpentier, Steven M Chan and 8 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Maria Agustina PerusiniDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. agusperusini@gmail.com.ORCID 0000-0003-1893-6096
Claire AndrewsDepartment of Haematology, St Vincent's University Hospital, Dublin, Ireland.
Atenafu G EshetuDepartment of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0002-4613-3680
Vikas GuptaDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0002-1419-8607
Dawn MazeDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0002-4598-9380
Karen W L YeeDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0002-2572-9952
Aniket BankarDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Marta B DavidsonDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Guillaume Richard-CarpentierDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0001-6452-8814
Steven M ChanDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0002-4354-0731
Aaron D SchimmerDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0003-4023-3899
Jad SibaiUniversity Health Network, Toronto, ON, Canada.
Salman AlharbiDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.ORCID 0000-0002-3150-9876
Josephine A LuceroDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Swe Mar LinnDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Mark D MindenDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Andre C Schuh *Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Hassan Sibai *Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsPrecursor Cell Lymphoblastic Leukemia-LymphomaAdultAntineoplastic Combined Chemotherapy ProtocolsAsparaginaseHumansAntineoplastic AgentsAsparaginase

Identifiers

PMID38431747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.